Skip to main content
. 2022 Dec 30;20(7):1949–1951. doi: 10.1111/ajt.15949

TABLE 1.

Considerations for performing renal transplants during the coronavirus disease 2019 (COVID-19) viral pandemic

Uncertainties Proceeding with transplant Deferring transplant
Evolving novel pathogen pandemic
Severity, extent, trajectory, and duration of the pandemic is unknown
  • Risk of healthcare-associated, community-acquired or donor-derived infection

  • Potential adverse psychosocial effects due to heightened infection control measures for recipients (eg, social distancing, prolonged isolation)

  • Risk of healthcare-associated (eg, dialysis center) or community-acquired infection

  • Adverse medical and psychosocial effects from prolonged dialysis (eg, recurrent dialysis access-related complications)

  • Loss of access to transplantation may be prolonged, with risk of exclusion from transplantation due to disease progression or death

  • Poorer posttransplant outcomes with prolonged duration on dialysis

Impact of COVID-19 in different population groups (eg, transplant vs dialysis patients)
  • COVID-19 may be more severe and potentially fulminant in transplant recipients, especially those with a higher net state of immunosuppression

  • Dialysis patients with medical comorbidities are likely also significantly vulnerable to severe COVID-19

Treatment and prophylaxis options not established
  • Therapeutics for trial purposes or compassionate use may exclude transplant patients

  • Risk of drug-drug interaction, especially with immunosuppressants

  • Reduction of immunosuppression to manage infection may put the graft at risk

  • Therapeutics for trial purposes or compassionate use may exclude dialysis patients

Impact on healthcare resources
  • Access to resources needed for transplantation may be disrupted

  • Transplant processes may compete for critical healthcare resources (eg, staff, medical supplies, and facilities) essential for pandemic response

  • Access to existing dialysis facilities may be affected

Risks to donor/caregivers
  • Risk of acquiring nosocomial COVID-19 in healthy individuals

  • Caregivers may be as likely to acquire the infection in the community if widespread transmission occurs